EcoDrugPlus

Alcohol Dehydrogenase 5 (Class Iii), Chi Polypeptide

Ensembl ID : ENSDORG00000009107
Gene Symbol: ADH5
3 Cross references
397 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSDORG00000011676
Gene Symbol: AKR1B1
4 Cross references
426 Possible Orthologues:

Alpha-Amylase 2b

Ensembl ID : ENSDORG00000028663
Gene Symbol: LOC105997112
3 Cross references
207 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSDORG00000004097
Gene Symbol: AOC1
2 Cross references
233 Possible Orthologues:

Amyloid P Component, Serum

Ensembl ID : ENSDORG00000005557
Gene Symbol: APCS
4 Cross references
402 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSDORG00000015018
Gene Symbol: APP
4 Cross references
279 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSDORG00000025101
Gene Symbol: AR
2 Cross references
276 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSDORG00000024749
Gene Symbol: AGTR1
3 Cross references
213 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSDORG00000029423
Gene Symbol: AGTR2
4 Cross references
195 Possible Orthologues:

Angiotensin-Converting Enzyme-Like

Ensembl ID : ENSDORG00000008685
Gene Symbol: LOC105998551
4 Cross references
92 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSDORG00000024310
Gene Symbol: APLNR
4 Cross references
172 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSDORG00000011694
Gene Symbol: APH1A
4 Cross references
138 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).